MICHELLE PRUETT: Open Payments
NPI 1538147533 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$629 in 29 payments from 6 companies in 2025. Trend: 2023 $979 · 2024 $1,435 · 2025 $629
Food & beverage: $622Education: $7
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $310 |
| Lilly USA, LLC | 7 | $184 |
| ABBVIE INC. | 3 | $48 |
| Amgen Inc. | 3 | $46 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| PFIZER INC. | 1 | $20 |
Products named: ZEPBOUND, Rybelsus, MOUNJARO, Ozempic, QULIPTA, OTEZLA, Wegovy, FARXIGA.
Industry payments across TX — which companies pay providers there.
